Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL31745076

Nc1nc(Cc2cccs2)nc2ccsc12.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 12/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ ADORA2A P29274 11/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.41
▸ MAPT P10636 3/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HTR6 P50406 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GBA1 P04062 1/20 0.38
▸ CRHBP P24387 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ CRHR2 Q13324 1/20 0.38
▸ PDE4A P27815 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31745005 0.89 ADORA1 (0.54) ADORA1ADORA3ADORA2AALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL31745024 0.76 ADORA2A (0.45) ADORA1ADORA2A
Trifluoroacetic Acid SCHEMBL6383554 0.70 CYP2C19 (0.49) HDAC3HDAC4HDAC1HDAC6ALDH1A1
Trifluoroacetic Acid SCHEMBL31745019 0.70 ADORA2A (0.44) ADORA1ADORA2APDE4APDE4BPDE4C
SCHEMBL31744975 0.69 ADORA1 (0.47) ADORA1ADORA3ADORA2AALDH1A1KMT2A
Formic Acid SCHEMBL31744989 0.69 ADORA2A (0.42) ADORA1ADORA2AALDH1A1MAPTKMT2A
Trifluoroacetic Acid SCHEMBL31745124 0.69 HDAC3 (0.39) ADORA1ADORA2AHDAC3HDAC4HDAC1
SCHEMBL30647945 0.68 ADORA3 (0.52) ADORA1ADORA3HDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL31570040 0.68 KDM4C (0.47) ADORA1ADORA2AHDAC3HDAC1HDAC6
Trifluoroacetic Acid SCHEMBL31745043 0.67 ADORA2A (0.44) ADORA1ADORA2AALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382305-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 PTC THERAPEUTICS INC (US) 2025-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382305-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 ATXN2, SMN1; SMN2, ATXN10 ADORA1 2438/4885ADORA3 519/4885ADORA2A 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback